tiprankstipranks
Solid Biosciences (SLDB)
NASDAQ:SLDB
US Market
Holding SLDB?
Track your performance easily

Solid Biosciences (SLDB) Financial Statements

558 Followers

Solid Biosciences Financial Overview

Solid Biosciences's market cap is currently ―. The company's EPS TTM is $-3.036; its P/E ratio is -1.97; Solid Biosciences is scheduled to report earnings on March 12, 2025, and the estimated EPS forecast is $-0.77. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 200.00K$ 300.00K---
Gross Profit$ 200.00K$ 300.00K---
EBIT$ -32.73M$ -24.98M$ -24.21M$ -22.27M$ -23.11M
EBITDA$ -32.32M$ -23.21M$ -23.88M$ -22.05M$ -22.53M
Net Income Common Stockholders$ -32.73M$ -25.07M$ -24.30M$ -20.34M$ -20.98M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 171.12M$ 190.27M$ 206.07M$ 123.64M$ 142.88M
Total Assets$ 211.83M$ 230.98M$ 248.69M$ 164.94M$ 184.73M
Total Debt$ 24.72M$ 25.30M$ 25.82M$ 26.27M$ 25.04M
Net Debt$ -146.40M$ -164.97M$ -180.25M$ -97.38M$ -117.85M
Total Liabilities$ 44.80M$ 37.74M$ 37.97M$ 38.46M$ 40.37M
Stockholders Equity$ 167.02M$ 193.25M$ 210.68M$ 126.48M$ 144.36M
Cash Flow-
Free Cash Flow$ -23.71M$ -21.79M$ -25.35M$ -20.91M$ -18.28M
Operating Cash Flow$ -23.70M$ -21.50M$ -25.20M$ -20.82M$ -17.90M
Investing Cash Flow$ -10.99M$ -5.18M$ -38.49M$ 45.30M$ -24.64M
Financing Cash Flow$ 3.26M$ 5.00M$ 107.24M$ 505.00K-
Currency in USD

Solid Biosciences Earnings and Revenue History

Solid Biosciences Debt to Assets

Solid Biosciences Cash Flow

Solid Biosciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis